Hyperlipidemia
Conditions
Brief summary
The purpose of this study is to determine whether the Lipid-lowing Tea is effective and safe in the treatment of Hyperlipidemia Patients
Interventions
DRUGLipid-lowing Tea
Sponsors
China Medical University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Inclusion criteria
* Patient aged 20-65 years;either sex * Patient diagnosed with hyperlipidemia(fasting levels of TC\>=200mg/dL),or TG\>=200mg/dL but \<400mg/dL,or LDL-C\>=130mg/dL) * Patient who has signed the informed consent form
Exclusion criteria
* Patient with pregnancy (or child bearing potential),or in lactation * Patient with any lipid regulating agents within 4 weeks prior to study period * Patient currently taking concomitant medications, such as oral contraceptives, or any medical treatment capable of interfering with lipid metabolism(eg thiazides, β-blockers, cyclosporins, itraconazole erythromycin,and danazol) * Patient with medical history of hypothyroidism, pancreatitis, cholestasis, nephrotic syndrome, gall bladder disease, primary biliary cirrhosis. * Patient with liver dysfunction (SGOT or SGPT\>2x ULN) * Patient with renal insufficiency (serum creatinine\>1.3mg/dL) * Patient with myocardial infarction,cerebrovascular disease,or major operations within 6 months prior to the study period.
Countries
Taiwan
Contacts
Primary ContactChia-I Tsai, V.S
Outcome results
None listed